excavatolide B
isolated from marine soft coral (Briareum excavatum); effectively inhibits TPA-induced vascular permeability in mouse skin; structure in first source
Also Known As:
BrD1 compound
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Sung, Ping-Jyun:
3 articles
(01/2017 - 04/2015)
|
2. | Jean, Yen-Hsuan:
2 articles
(01/2017 - 04/2015)
|
3. | Lin, Sung-Chun:
2 articles
(01/2017 - 04/2015)
|
4. | Lin, Yen-You:
2 articles
(01/2017 - 04/2015)
|
5. | Wen, Zhi-Hong:
2 articles
(01/2017 - 04/2015)
|
6. | Ghaedi, Kamran:
1 article
(04/2018)
|
7. | Momenzadeh, Sara:
1 article
(04/2018)
|
8. | Nasr Esfahani, Mohammad Hossein:
1 article
(04/2018)
|
9. | Seyed Forootan, Farzad:
1 article
(04/2018)
|
10. | Yousefnia, Saghar:
1 article
(04/2018)
|
Related Diseases
1. | Neoplasms (Cancer)
04/05/2018
- " This review, specifically deals with anti-tumor and tumorigenicity effects of PPARγ and its natural and synthetic agonists including Troglitazone, Cladosporol A, B, 15-Deoxi-Δ12-14-Prostaglondin J2 (15-d-PGJ2), Ciglitazon, docosahexaenoic acid, eicosapentaenoic acid Alpha-eleostreac acid, Amorfrutin C, Sphingosine 1-phosphate, Evodiamine, Excavatolide B vs respected antagonists as GW9662, bisphenol-A-diglycidyl-ether. "
|
2. | Lung Neoplasms (Lung Cancer)
|
3. | Hyperalgesia
|
4. | Edema (Dropsy)
|
5. | Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
|
|
Related Drugs and Biologics